MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
19.26
-0.13 (-0.67%)
At close: Jun 27, 2025, 4:00 PM
19.26
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:15 PM EDT
MediWound Revenue
MediWound had revenue of $3.96M in the quarter ending March 31, 2025, a decrease of -20.33%. This brings the company's revenue in the last twelve months to $19.21M, down -3.21% year-over-year. In the year 2024, MediWound had annual revenue of $20.22M with 8.22% growth.
Revenue (ttm)
$19.21M
Revenue Growth
-3.21%
P/S Ratio
10.47
Revenue / Employee
$173,090
Employees
111
Market Cap
208.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.22M | 1.54M | 8.22% |
Dec 31, 2023 | 18.69M | -7.81M | -29.48% |
Dec 31, 2022 | 26.50M | 2.73M | 11.50% |
Dec 31, 2021 | 23.76M | 2.00M | 9.19% |
Dec 31, 2020 | 21.76M | -10.03M | -31.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MDWD News
- 5 weeks ago - MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - MediWound Ltd.: Undervalued High-Growth Potential - Seeking Alpha
- 6 weeks ago - MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers - GlobeNewsWire
- 7 weeks ago - MediWound to Report First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - MediWound to Present New EscharEx® Data at Leading Wound Care Conferences - GlobeNewsWire
- 3 months ago - MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire